The Use of β-Adrenergic Receptor Antagonists in Psychiatry: A Review
Authors:
- 1 July 2021
- journal article
- review article
- Published by Elsevier in Journal of the Academy of Consultation-Liaison Psychiatry
- Vol. 62 (4) , 404-412
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: Recommendations for patient informationInternational Journal of Cardiology, 2013
- Aliskiren, ALTITUDE, and the Implications for ATMOSPHEREEuropean Journal of Heart Failure, 2012
- Antipsychotic Pharmacotherapy and Orthostatic HypotensionCNS Drugs, 2011
- Beta-Blocker Supplementation of Standard Drug Treatment for SchizophreniaSchizophrenia Bulletin, 2010
- Acute antipsychotic-induced akathisia revisitedThe British Journal of Psychiatry, 2010
- Adrenergic pharmacology and cognition: Focus on the prefrontal cortexPharmacology & Therapeutics, 2007
- Calcium and Beta Receptor Antagonist Overdose: A Review and Update of Pharmacological Principles and ManagementSeminars in Respiratory and Critical Care Medicine, 2002
- Pharmacotherapy of mania: A reviewInternational Journal of Psychiatry in Clinical Practice, 2000
- A Controlled Study of Alprazolam and Propranolol inJournal of Clinical Psychopharmacology, 1991
- Beneficial effect of nadolol on anxiety-induced disturbances of performance in musicians: A comparison with diazepam and placeboAmerican Heart Journal, 1984